Semler Scientific, Inc. (SMLR), a med tech company with a sub $500 million market cap, has seen a significant stock price increase following its decision to adopt Bitcoin as a treasury asset. The company's stock surged by 30% after the announcement, and it has risen by 40% over the week. This decision was influenced by the approval of a Bitcoin ETF, which Semler Scientific believes validates the future institutional adoption of Bitcoin. As of March 31, Semler Scientific reported $72 million in total current assets and $6 million in total liabilities, indicating substantial room to leverage and potentially acquire more Bitcoin. The company is GAAP profitable and has positive cash flow, making it an intriguing investment opportunity.
$SMLR has $72 million in total current assets as of 3/31 and about $6 million total liabilities. There’s a lot of room to lever up, take on debt, and buy more $BTC. GAAP profitable & cash flow+. This is an interesting play. @BenWerkman @PunterJeff @saylor @DylanLeClair_ @ryQuant https://t.co/hH1NIkegNy
More and more companies are going to buy $BTC for their treasuries. Just look at what happened to $SMLR stock after they did.
$GME Okay, let’s talk about this… A med tech company no one has ever heard about before $SMLR with a sub $500M market cap is up 40% this week because they bought Bitcoin. There is no way Ryan Cohen isn’t atleast thinking of buying Bitcoin with the new cash he raised.. If… https://t.co/vYN3LxKzHQ https://t.co/KmtabtuMM3